Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG

Coronavirus disease 2019 (COVID-19) convalescent plasma has emerged as a promising therapy and has been granted Emergency Use Authorization by the US Food and Drug Administration for hospitalized COVID-19 patients. We recently reported results from interim analysis of a propensity score–matched stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar, Eric, Christensen, Paul A., Graviss, Edward A., Nguyen, Duc T., Castillo, Brian, Chen, Jian, Lopez, Bevin V., Eagar, Todd N., Yi, Xin, Zhao, Picheng, Rogers, John, Shehabeldin, Ahmed, Joseph, David, Masud, Faisal, Leveque, Christopher, Olsen, Randall J., Bernard, David W., Gollihar, Jimmy, Musser, James M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Investigative Pathology. Published by Elsevier Inc. 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609241/
https://www.ncbi.nlm.nih.gov/pubmed/33157066
http://dx.doi.org/10.1016/j.ajpath.2020.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609241/
https://www.ncbi.nlm.nih.gov/pubmed/33157066
http://dx.doi.org/10.1016/j.ajpath.2020.10.008

Ejemplares similares